Urine-based test for detecting bladder cancer
Nucleix has raised €49M across 2 funding rounds from 3 investors, most recently a round in Apr 2021. Based in Rehovot, Israel; founded 2008; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2021-04-07 | Other | €47M | RA Capital Management | View deal → |
| 2016-05-01 | Seed | €2.7M | Aurum Ventures,OrbiMed | View deal → |
